The APOE ε4 (APOE4) genotype may contribute to the maintenance of cognitive function in the absence of tau protein pathology, but once tau protein pathology emerges, ApoE4 promotes the formation of pathological structures and increases the risk of AD. Here, MAPT is linked to Alzheimer disease.